about
Phylogenetic analysis of a swine influenza A(H3N2) virus isolated in Korea in 2012Original Antigenic Sin Response to RNA Viruses and Antiviral ImmunityIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningMolecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009-2011.Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza virusesThe anti-influenza virus effect of Phellinus igniarius extract.DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.Effects of a hemagglutinin D222G substitution on the pathogenicity of 2009 influenza A (H1N1) virus in mice.Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral HemagglutininRapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice.The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in MiceSynergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.Genetic diversity of HA1 domain of hemagglutinin gene of pandemic influenza H1N1pdm09 viruses in New Delhi, India.TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccineCD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesGenetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolutionN-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protectionIn vivo assessment of NS1-truncated influenza virus with a novel SLSYSINWRH motif as a self-adjuvanting live attenuated vaccineNew Metrics for Evaluating Viral Respiratory Pathogenesis.Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species.Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae.Antibodies to influenza virus A/H1N1 hemagglutinin in Type 1 diabetes children diagnosed before, during and after the SWEDISH A(H1N1)pdm09 vaccination campaign 2009-2010.GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents.Sentinel surveillance for influenza and other respiratory viruses in Côte d'Ivoire, 2003-2010.Towards the Application of Human Defensins as Antivirals.Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection.
P2860
Q27322031-ECB27E2E-28F0-4D1B-9155-3AAFB9DCB183Q28066918-B3FAF0F5-5D3C-4A1C-B5E5-0DC80168B0A4Q28830304-0AE72AD5-16A0-41D4-90F6-C8BE0E6CF445Q30354016-6C7A3378-9871-4F55-8C03-AD0F83189755Q30354832-388F3D05-F95B-442D-807A-60D5EED80889Q30355058-BFA243A7-E306-48DB-A8A5-28385EB21DF5Q30357472-BEDE3D24-C0F7-484C-B836-D38F70F2E8B0Q30360144-344C0058-4DA9-4A98-9852-12A86AC44A32Q30362512-988AC994-FFD2-4755-B0C8-39A5C34B9151Q30365243-1DE1A953-D44A-44B7-A1FD-A460F66CABBFQ30375215-BFD1FA7B-BFE6-4B2D-9C48-3794DF3B973CQ30375250-2CB576E9-795B-4DC2-A60E-E9287C166BDCQ30382370-4FCF913F-B824-4091-B184-D305ED129DF9Q30399993-AD6CA81E-2D86-43B3-B4DE-8689D65F9CBEQ30411781-66451C34-7956-49D7-ADAD-82B4F0EB28C8Q30419734-D6AD7947-0289-4BE0-A5F9-FC5653F9F895Q30421413-5E5A843E-87AB-4D75-A935-32BA4017F217Q30423542-1814A6A9-1CB6-404A-84C9-5276A571B302Q30426345-FC201541-64B1-4D36-A506-E8D76C80DEADQ30427591-EBF248D1-C410-425F-912C-308B0754A8E2Q30430014-BD60700C-F3B1-4A0A-A234-927BA3DD9505Q30431513-DE40B408-5296-4974-ADD8-0DF99C8CF0ACQ30432710-1D766A67-2005-4279-82C5-558F62DB4412Q34059067-31BC3B63-FCEA-46A9-B9B6-1000598699B5Q35565480-178A3C6B-17EC-4DFF-AE23-CFC472C670AAQ35581453-CB800025-1E0F-4C3E-BC50-11A16A81320DQ35675833-1A9CC0E7-06A6-4633-A11D-46E31A4FBAAEQ37716213-46B3A26A-4CCF-4349-ABEE-333F0E7A4B9EQ38078403-5E15B5D2-8879-46AB-A226-26D3A68A2D81Q38974742-BC87919A-B19F-4296-99D9-FA8769F59D05Q42185880-CBD498A6-3950-435A-989F-C4C89CC31A4CQ42250705-57049FDF-D4C7-410D-9777-36A2B0C4F263Q45357981-D029E3AB-B516-4A44-88B9-618388CF1600Q47304190-73B3F19D-8935-4215-AF9E-AD3B59FC5B2EQ47557198-8823EFE4-6229-4F8A-B1B7-B93A0387DAB8Q50356107-B3E57264-3EB7-457F-9055-F42D344C08AC
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The first influenza pandemic of the new millennium.
@ast
The first influenza pandemic of the new millennium.
@en
type
label
The first influenza pandemic of the new millennium.
@ast
The first influenza pandemic of the new millennium.
@en
prefLabel
The first influenza pandemic of the new millennium.
@ast
The first influenza pandemic of the new millennium.
@en
P2860
P921
P1476
The first influenza pandemic of the new millennium.
@en
P2093
Gabriele Neumann
P2860
P304
P356
10.1111/J.1750-2659.2011.00231.X
P577
2011-02-28T00:00:00Z
2011-05-01T00:00:00Z